Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Caliway Biopharmaceuticals Co. Ltd. has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 3 distinct art units, indicating that the company's pharmaceutical research covers several different specialized fields. The prosecution is further diversified by the involvement of 4 distinct examiners, meaning every active case is being reviewed by a unique official at the patent office. This decentralized structure suggests that the company's intellectual property strategy must account for a wide range of examiner perspectives and departmental standards.
The busiest examiner, SHAMEEM, GOLAM M, is managing 1 pending office action. This highlights a workload where no single examiner has a dominant role across the portfolio. For practitioners, this requires managing multiple examiner relationships while simultaneously navigating the specific standards and guidelines of the 3 distinct art units. The lack of examiner overlap across the pending office actions means that prosecution strategies must be independently developed for each application to address the specific concerns of the various officials.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| §102 only | 1 (25%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHAMEEM, GOLAM M | 1 | 86.7% | +16.0% |
| MELLER, MICHAEL V | 1 | 47.1% | +28.2% |
| GALSTER, SAMUEL LEONARD | 1 | 50.9% | +43.2% |
| YU, HONG | 1 | 30.9% | +5.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18762851 | PHARMACEUTICAL COMPOSITIONS FOR USE IN REDUCING HYPERPIGMENTATION | SHAMEEM, GOLAM M | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18762851 | PHARMACEUTICAL COMPOSITIONS FOR USE IN REDUCING HYPERPIGMENTATION | SHAMEEM, GOLAM M | — |
| 18466003 | METHOD FOR TREATING AND/OR PREVENTING EDEMATOUS FIBROSCLEROTIC PANNICULOPATHY | MELLER, MICHAEL V | — |
| 18317564 | COMPOSITIONS AND METHODS FOR ALLEVIATING CONDITIONS CAUSED BY ABNORMAL SUBCUTANEOUS DEPOSIT OF ADIPOSE TISSUE OR FAT | GALSTER, SAMUEL LEONARD | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| 1693 | 1 |
| 1614 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18762851 | PHARMACEUTICAL COMPOSITIONS FOR USE IN REDUCING HYPERPIGMENTATION | SHAMEEM, GOLAM M | — | §102 | Non-Final OA | — | Pending | Jul 03, 2024 |
| 18466003 | METHOD FOR TREATING AND/OR PREVENTING EDEMATOUS FIBROSCLEROTIC PANNICULOPATHY | MELLER, MICHAEL V | 1655 | §103 | Final Rejection | — | Pending | Sep 13, 2023 |
| 18317564 | COMPOSITIONS AND METHODS FOR ALLEVIATING CONDITIONS CAUSED BY ABNORMAL SUBCUTANEOUS DEPOSIT OF ADIPOSE TISSUE OR FAT | GALSTER, SAMUEL LEONARD | 1693 | §102§103DP | Non-Final OA | — | Pending | May 15, 2023 |
| 15754363 | A PHARMACEUTICAL COMPOSITION FOR REDUCING LOCAL FAT AND USES THEREOF | YU, HONG | 1614 | §102§103§112 | Non-Final OA | — | Pending | Feb 22, 2018 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial